Suppr超能文献

数据是否支持营养支持?第一部分:静脉营养。

Do data support nutrition support? Part I: intravenous nutrition.

作者信息

Koretz Ronald L

机构信息

Department of Medicine, Olive View UCLA Medical Center, Sylmar, CA 91342, USA.

出版信息

J Am Diet Assoc. 2007 Jun;107(6):988-96; quiz 998. doi: 10.1016/j.jada.2007.03.015.

Abstract

Intravenous (parenteral) nutrition has been advocated widely as adjunctive care in patients with a variety of underlying diseases. However, the enthusiasm for this therapeutic intervention was based largely on expert opinion. Because the best way to assess the efficacy of any treatment is to test it in a randomized controlled trial, this review will focus on data that was derived from such studies. Using established search strategies, randomized controlled trials were sought that compared one of two forms of intravenous nutrition: parenteral nutrition (nitrogen and >or=10 kcal/kg/day of non-protein calories for >or=5 days) or protein-sparing therapy (nitrogen and fewer non-protein calories) with no type of artificial nutrition beyond regular food and/or standard (5%) dextrose. The randomized controlled trials were stratified by the underlying disease state. The clinical outcomes of interest were mortality, morbidity (total/infectious complications), and/or duration of hospitalization. More than 100 randomized controlled trials failed for the most part to demonstrate that intravenous nutrition had any effect on clinical outcome. There were a few exceptions. In patients undergoing attempted curative surgery for upper gastrointestinal cancer, the use of preoperative parenteral nutrition seemed to reduce the incidence of major postoperative complications. However, this benefit was only found in low-quality randomized controlled trials. Findings conflict regarding the use of parenteral nutrition in patients with acute pancreatitis or undergoing bone marrow transplantation. Parenteral nutrition was harmful when provided to patients undergoing radiation or chemotherapy for cancer. Although no randomized controlled trials exist, it is assumed that parenteral nutrition is useful in patients with an inadequate gastrointestinal tract ("short gut"). Thus, for the most part, randomized controlled trials comparing intravenous nutrition to no artificial nutrition have not shown that this medical intervention is of benefit.

摘要

静脉(胃肠外)营养作为多种基础疾病患者的辅助治疗方法已得到广泛提倡。然而,对这种治疗干预措施的热情很大程度上基于专家意见。由于评估任何治疗效果的最佳方法是在随机对照试验中进行测试,因此本综述将重点关注来自此类研究的数据。采用既定的检索策略,寻找比较两种静脉营养形式之一的随机对照试验:胃肠外营养(氮和≥10千卡/千克/天的非蛋白质热量,持续≥5天)或蛋白质节省疗法(氮和较少的非蛋白质热量)与除常规食物和/或标准(5%)葡萄糖之外的任何类型的人工营养进行比较。随机对照试验按基础疾病状态进行分层。感兴趣的临床结局为死亡率、发病率(总/感染性并发症)和/或住院时间。100多项随机对照试验大多未能证明静脉营养对临床结局有任何影响。有一些例外情况。在接受上消化道癌根治性手术尝试的患者中,术前使用胃肠外营养似乎可降低术后主要并发症的发生率。然而,这种益处仅在低质量的随机对照试验中发现。关于在急性胰腺炎患者或接受骨髓移植的患者中使用胃肠外营养的研究结果存在冲突。胃肠外营养对接受癌症放疗或化疗的患者有害。尽管不存在随机对照试验,但据推测胃肠外营养对胃肠道功能不全(“短肠”)患者有用。因此,在很大程度上,比较静脉营养与不使用人工营养的随机对照试验并未表明这种医学干预有益处。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验